Electrospun Biopolymer as a Therapeutic Agent in Cancer Treatment

References

1. ChandraprasadM.S. DeyA. SwamyM.K. Introduction to cancer and treatment approaches.In: Paclitaxel.Elsevier202212710.1016/B978‑0‑323‑90951‑8.00010‑2
   [Google Scholar]
2. ClappR.W. JacobsM.M. LoechlerE.L. Environmental and occupational causes of cancer: new evidence 2005-2007.Rev. Environ. Health200823113810.1515/REVEH.2008.23.1.1 18557596
   [Google Scholar]
3. AmesB.N. GoldL.S. WillettW.C. The causes and prevention of cancer.Proc. Natl. Acad. Sci. USA199592125258526510.1073/pnas.92.12.5258 7777494
   [Google Scholar]
4. KeyT.J. SchatzkinA. WillettW.C. AllenN.E. SpencerE.A. TravisR.C. Diet, nutrition and the prevention of cancer.Public Health Nutr.200471a18720010.1079/PHN2003588 14972060
   [Google Scholar]
5. PonderB.A.J. Cancer genetics.Nature2001411683533634110.1038/35077207 11357140
   [Google Scholar]
6. VogelsteinB. KinzlerK.W. Cancer genes and the pathways they control.Nat. Med.200410878979910.1038/nm1087 15286780
   [Google Scholar]
7. LawrenceM.S. StojanovP. PolakP. Mutational heterogeneity in cancer and the search for new cancer-associated genes.Nature2013499745721421810.1038/nature12213 23770567
   [Google Scholar]
8. LillieA.K. Exploring cancer genetics and care of the family: an evolving challenge for palliative care.Int. J. Palliat. Nurs.2006122707410.12968/ijpn.2006.12.2.20533 16603995
   [Google Scholar]
9. BrennerH. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis.Lancet200236093401131113510.1016/S0140‑6736(02)11199‑8 12387961
   [Google Scholar]
10. TaiakinaD. PraA.D. BristowR.G. Intratumoral hypoxia as the genesis of genetic instability and clinical prognosis in prostate cancer.Adv. Exp. Med. Biol.201477218920410.1007/978‑1‑4614‑5915‑6_9
    [Google Scholar]
11. ParadkarP.H. JoshiJ.V. MertiaP.N. AgasheS.V. VaidyaR.A. Role of cytokines in genesis, progression and prognosis of cervical cancer.Asian Pac. J. Cancer Prev.20141593851386410.7314/APJCP.2014.15.9.3851 24935564
    [Google Scholar]
12. NicholsonJ.M. CiminiD. Cancer karyotypes: survival of the fittest.Front. Oncol.2013314810.3389/fonc.2013.00148 23760367
    [Google Scholar]
13. ZhangQ. ZhangQ. CongH. ZhangX. The ectopic expression of BRCA1 is associated with genesis, progression, and prognosis of breast cancer in young patients.Diagn. Pathol.20127118110.1186/1746‑1596‑7‑181 23276146
    [Google Scholar]
14. Peshes-YelozN. UngarL. WohlA. Role of klotho protein in tumor genesis, cancer progression, and prognosis in patients with high-grade glioma.World Neurosurg.2019130e324e33210.1016/j.wneu.2019.06.082 31228703
    [Google Scholar]
15. WangJ. LiW. WangY. The H6D genetic variation of GDF15 is associated with genesis, progress and prognosis in colorectal cancer.Pathol. Res. Pract.20152111184585010.1016/j.prp.2015.08.004 26365480
    [Google Scholar]
16. SunY. ChengS. LuW. WangY. ZhangP. YaoQ. Electrospun fibers and their application in drug controlled release, biological dressings, tissue repair, and enzyme immobilization.RSC Advances2019944257122572910.1039/C9RA05012D 35530076
    [Google Scholar]
17. BhardwajN. KunduS.C. Electrospinning: A fascinating fiber fabrication technique.Biotechnol. Adv.201028332534710.1016/j.biotechadv.2010.01.004 20100560
    [Google Scholar]
18. ShahriarS. MondalJ. HasanM. RevuriV. LeeD. LeeY.K. Electrospinning nanofibers for therapeutics delivery.Nanomaterials (Basel)20199453210.3390/nano9040532 30987129
    [Google Scholar]
19. WangC. ChengY.W. HsuC.H. ChienH.S. TsouS.Y. How to manipulate the electrospinning jet with controlled properties to obtain uniform fibers with the smallest diameter?a brief discussion of solution electrospinning process.J. Polym. Res.201118111112310.1007/s10965‑010‑9397‑1
    [Google Scholar]
20. De VriezeS. Van CampT. NelvigA. HagströmB. WestbroekP. De ClerckK. The effect of temperature and humidity on electrospinning.J. Mater. Sci.20094451357136210.1007/s10853‑008‑3010‑6
    [Google Scholar]
21. HaoM.F. LiuY. HeX.T. DingY.M. YangW.M. Factors influencing diameter of polypropylene fiber in melt electrospinning.Adv. Mater Res.201122112913410.4028/www.scientific.net/AMR.221.129
    [Google Scholar]
22. SuY. LuB. XieY. Temperature effect on electrospinning of nanobelts: the case of hafnium oxide.Nanotechnology2011222828560910.1088/0957‑4484/22/28/285609 21659687
    [Google Scholar]
23. MedeirosE.S. MattosoL.H.C. ItoE.N. Electrospun Nanofibers of Poly(vinyl alcohol) Reinforced with Cellulose Nanofibrils.J. Biobased Mater. Bioenergy20082323124210.1166/jbmb.2008.411
    [Google Scholar]
24. ChanthakulchanA. KoomsapP. ParkhiA.A. SupapholP. Environmental effects in fibre fabrication using electrospinning-based rapid prototyping.Virtual Phys. Prototyp.201510422723710.1080/17452759.2015.1112411
    [Google Scholar]
25. ThomaC.R. ZimmermannM. AgarkovaI. KelmJ.M. KrekW. 3D cell culture systems modeling tumor growth determinants in cancer target discovery.Adv. Drug Deliv. Rev.201469-70294110.1016/j.addr.2014.03.001 24636868
    [Google Scholar]
26. KievitF.M. FlorczykS.J. LeungM.C. Proliferation and enrichment of CD133+ glioblastoma cancer stem cells on 3D chitosan-alginate scaffolds.Biomaterials201435339137914310.1016/j.biomaterials.2014.07.037 25109438
    [Google Scholar]
27. RanganathS.H. WangC.H. Biodegradable microfiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma.Biomaterials200829202996300310.1016/j.biomaterials.2008.04.002 18423584
    [Google Scholar]
28. HutmacherD.W. Biomaterials offer cancer research the third dimension.Nat. Mater.201092909310.1038/nmat2619 20094076
    [Google Scholar]
29. BrancoM.C. SiganoD.M. SchneiderJ.P. Materials from peptide assembly: towards the treatment of cancer and transmittable disease.Curr. Opin. Chem. Biol.201115342743410.1016/j.cbpa.2011.03.021 21507707
    [Google Scholar]
30. KievitF.M. WangF.Y. FangC. Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro.J. Control. Release20111521768310.1016/j.jconrel.2011.01.024 21277920
    [Google Scholar]
31. HindererS. LaylandS.L. Schenke-LaylandK. ECM and ECM-like materials - Biomaterials for applications in regenerative medicine and cancer therapy.Adv. Drug Deliv. Rev.20169726026910.1016/j.addr.2015.11.019 26658243
    [Google Scholar]
32. BriggerI. DubernetC. CouvreurP. Nanoparticles in cancer therapy and diagnosis.Adv. Drug Deliv. Rev.200254563165110.1016/S0169‑409X(02)00044‑3 12204596
    [Google Scholar]
33. TaH.T. DassC.R. DunstanD.E. Injectable chitosan hydrogels for localised cancer therapy.J. Control. Release2008126320521610.1016/j.jconrel.2007.11.018 18258328
    [Google Scholar]
34. RamachandranR. JunnuthulaV.R. GowdG.S. Theranostic 3-Dimensional nano brain-implant for prolonged and localized treatment of recurrent glioma.Sci. Rep.2017714327110.1038/srep43271 28262735
    [Google Scholar]
35. BagóJ.R. PegnaG.J. OkolieO. Mohiti-AsliM. LoboaE.G. HingtgenS.D. Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma.Biomaterials20169011612510.1016/j.biomaterials.2016.03.008 27016620
    [Google Scholar]
36. WeiJ. LuoX. ChenM. LuJ. LiX. Spatial distribution and antitumor activities after intratumoral injection of fragmented fibers with loaded hydroxycamptothecin.Acta Biomater.20152318920010.1016/j.actbio.2015.05.020 26013039
    [Google Scholar]
37. MaP.X. ZhangR. Synthetic nano-scale fibrous extracellular matrix.J. Biomed. Mater. Res.1999461607210.1002/(SICI)1097‑4636(199907)46:1<60:AID‑JBM7>3.0.CO;2‑H 10357136
    [Google Scholar]
38. AnisieiA. OanceaF. MarinL. Electrospinning of chitosan-based nanofibers: from design to prospective applications.Rev. Chem. Eng.2023391317010.1515/revce‑2021‑0003
    [Google Scholar]
39. VenugopalJ. RamakrishnaS. Biocompatible nanofiber matrices for the engineering of a dermal substitute for skin regeneration.Tissue Eng.2005115-684785410.1089/ten.2005.11.847 15998224
    [Google Scholar]
40. PillayV. DottC. ChoonaraY.E. A review of the effect of processing variables on the fabrication of electrospun nanofibers for drug delivery applications.J. Nanomater.2013201312210.1155/2013/789289
    [Google Scholar]
41. KimW.J. KwonY.J. ChoC.H. YeS.K. KimK.O. Insulin smart drug delivery nanoparticles of aminophenylboronic acid–POSS molecule at neutral pH.Sci. Rep.20211112189410.1038/s41598‑021‑01216‑3 34750459
    [Google Scholar]
42. LiD. XiaY. Electrospinning of nanofibers: Reinventing the wheel?Adv. Mater.200416141151117010.1002/adma.200400719
    [Google Scholar]
43. ProcessE. An Introduction to Electrospinning and Nanofibers.WORLD SCIENTIFIC200590154
    [Google Scholar]
44. YeK. KuangH. YouZ. MorsiY. MoX. Electrospun nanofibers for tissue engineering with drug loading and release.Pharmaceutics201911418210.3390/pharmaceutics11040182 30991742
    [Google Scholar]
45. JunI. HanH.S. EdwardsJ. JeonH. Electrospun fibrous scaffolds for tissue engineering: viewpoints on architecture and fabrication.Int. J. Mol. Sci.201819374510.3390/ijms19030745 29509688
    [Google Scholar]
46. ZhuX. CuiW. LiX. JinY. Electrospun fibrous mats with high porosity as potential scaffolds for skin tissue engineering.Biomacromolecules2008971795180110.1021/bm800476u 18578495
    [Google Scholar]
47. LuoH. JieT. ZhengL. HuangC. ChenG. CuiW. Electrospun nanofibers for cancer therapy.Adv. Exp. Med. Biol.2021129516319010.1007/978‑3‑030‑58174‑9_8
    [Google Scholar]
48. KenawyE.R. BowlinG.L. MansfieldK. Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend.J. Control. Release2002811-2576410.1016/S0168‑3659(02)00041‑X 11992678
    [Google Scholar]
49. YoheS.T. HerreraV.L.M. ColsonY.L. GrinstaffM.W. 3D superhydrophobic electrospun meshes as reinforcement materials for sustained local drug delivery against colorectal cancer cells.J. Control. Release201216219210110.1016/j.jconrel.2012.05.047 22684120
    [Google Scholar]
50. ZongS. WangX. YangY. The use of cisplatin-loaded mucoadhesive nanofibers for local chemotherapy of cervical cancers in mice.Eur. J. Pharm. Biopharm.20159312713510.1016/j.ejpb.2015.03.029 25843238
    [Google Scholar]
51. ToshkovaR. ManolovaN. GardevaE. Antitumor activity of quaternized chitosan-based electrospun implants against Graffi myeloid tumor.Int. J. Pharm.20104001-222123310.1016/j.ijpharm.2010.08.039 20816737
    [Google Scholar]
52. WeiJ. HuJ. LiM. ChenY. ChenY. Multiple drug-loaded electrospun PLGA/gelatin composite nanofibers encapsulated with mesoporous ZnO nanospheres for potential postsurgical cancer treatment.RSC Advances2014453280112801910.1039/C4RA03722G
    [Google Scholar]
53. XieJ. WangC.H. Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro.Pharm. Res.20062381817182610.1007/s11095‑006‑9036‑z 16841195
    [Google Scholar]
54. XuX. ChenX. WangZ. JingX. Ultrafine PEG–PLA fibers loaded with both paclitaxel and doxorubicin hydrochloride and their in vitro cytotoxicity.Eur. J. Pharm. Biopharm.2009721182510.1016/j.ejpb.2008.10.015 19027067
    [Google Scholar]
55. LuoX. XieC. WangH. LiuC. YanS. LiX. Antitumor activities of emulsion electrospun fibers with core loading of hydroxycamptothecin via intratumoral implantation.Int. J. Pharm.20124251-2192810.1016/j.ijpharm.2012.01.012 22265915
    [Google Scholar]
56. LuoX. ZhangH. ChenM. WeiJ. ZhangY. LiX. Antimetastasis and antitumor efficacy promoted by sequential release of vascular disrupting and chemotherapeutic agents from electrospun fibers.Int. J. Pharm.20144751-243844910.1016/j.ijpharm.2014.09.006 25218185
    [Google Scholar]
57. ChenP. WuQ.S. DingY.P. ChuM. HuangZ.M. HuW. A controlled release system of titanocene dichloride by electrospun fiber and its antitumor activity in vitro.Eur. J. Pharm. Biopharm.201076341342010.1016/j.ejpb.2010.09.005 20854905
    [Google Scholar]
58. XuX. ChenX. XuX. BCNU-loaded PEG–PLLA ultrafine fibers and their in vitro antitumor activity against Glioma C6 cells.J. Control. Release2006114330731610.1016/j.jconrel.2006.05.031 16891029
    [Google Scholar]
59. ShaoS. LiL. YangG. Controlled green tea polyphenols release from electrospun PCL/MWCNTs composite nanofibers.Int. J. Pharm.2011421231032010.1016/j.ijpharm.2011.09.033 21983092
    [Google Scholar]
60. GuoG. FuS. ZhouL. Preparation of curcumin loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanofibers and their in vitro antitumor activity against Glioma 9L cells.Nanoscale2011393825383210.1039/c1nr10484e 21847493
    [Google Scholar]
61. SongM. GuoD. PanC. The application of poly(N -isopropylacrylamide)-co-polystyrene nanofibers as an additive agent to facilitate the cellular uptake of an anticancer drug.Nanotechnology2008191616510210.1088/0957‑4484/19/16/165102 21825633
    [Google Scholar]
62. LvG. HeF. WangX. Novel nanocomposite of nano fe(3)o(4) and polylactide nanofibers for application in drug uptake and induction of cell death of leukemia cancer cells.Langmuir20082452151215610.1021/la702845s 18193905
    [Google Scholar]
63. LeiC. CuiY. ZhengL. Kah-Hoe ChowP. WangC.H. Development of a gene/drug dual delivery system for brain tumor therapy: Potent inhibition via RNA interference and synergistic effects.Biomaterials201334307483749410.1016/j.biomaterials.2013.06.010 23820014
    [Google Scholar]
64. OkadaT. NiiyamaE. UtoK. AoyagiT. EbaraM. Inactivated sendai virus (HVJ-E) immobilized electrospun nanofiber for cancer therapy.Materials (Basel)2015911210.3390/ma9010012 28787810
    [Google Scholar]
65. LinT.C. LinF.H. LinJ.C. In vitro feasibility study of the use of a magnetic electrospun chitosan nanofiber composite for hyperthermia treatment of tumor cells.Acta Biomater.2012872704271110.1016/j.actbio.2012.03.045 22484694
    [Google Scholar]
66. ZengJ. YangL. LiangQ. Influence of the drug compatibility with polymer solution on the release kinetics of electrospun fiber formulation.J. Control. Release20051051-2435110.1016/j.jconrel.2005.02.024 15908033
    [Google Scholar]
67. KimK. LuuY.K. ChangC. Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds.J. Control. Release2004981475610.1016/j.jconrel.2004.04.009 15245888
    [Google Scholar]
68. SultanovaZ. KaleliG. KabayG. MutluM. Controlled release of a hydrophilic drug from coaxially electrospun polycaprolactone nanofibers.Int. J. Pharm.20165051-213313810.1016/j.ijpharm.2016.03.032 27012983
    [Google Scholar]
69. QiH. HuP. XuJ. WangA. Encapsulation of drug reservoirs in fibers by emulsion electrospinning: morphology characterization and preliminary release assessment.Biomacromolecules2006782327233010.1021/bm060264z 16903678
    [Google Scholar]
70. HanD. StecklA.J. Triaxial electrospun nanofiber membranes for controlled dual release of functional molecules.ACS Appl. Mater. Interfaces20135168241824510.1021/am402376c 23924226
    [Google Scholar]
71. SongB. WuC. ChangJ. Dual drug release from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats with distinct release profiles.Acta Biomater.2012851901190710.1016/j.actbio.2012.01.020 22326789
    [Google Scholar]
72. XieJ. MacEwanM.R. LiX. Sakiyama-ElbertS.E. XiaY. Neurite outgrowth on nanofiber scaffolds with different orders, structures, and surface properties.ACS Nano2009351151115910.1021/nn900070z 19397333
    [Google Scholar]
73. XieJ. LiuW. MacEwanM.R. BridgmanP.C. XiaY. Neurite outgrowth on electrospun nanofibers with uniaxial alignment: the effects of fiber density, surface coating, and supporting substrate.ACS Nano2014821878188510.1021/nn406363j 24444076
    [Google Scholar]
74. XieJ. MacEwanM.R. WillerthS.M. Conductive core-sheath nanofibers and their potential application in neural tissue engineering.Adv. Funct. Mater.200919142312231810.1002/adfm.200801904 19830261
    [Google Scholar]
75. LiX. XieJ. LipnerJ. YuanX. ThomopoulosS. XiaY. Nanofiber scaffolds with gradations in mineral content for mimicking the tendon-to-bone insertion site.Nano Lett.2009972763276810.1021/nl901582f 19537737
    [Google Scholar]
76. PengQ. SunX.Y. SpagnolaJ.C. HydeG.K. SpontakR.J. ParsonsG.N. Atomic layer deposition on electrospun polymer fibers as a direct route to AL2O3 microtubes with precise wall thickness control.Nano Lett.20077371972210.1021/nl062948i 17279801
    [Google Scholar]
77. LiX. XieJ. YuanX. XiaY. Coating electrospun poly(ε-caprolactone) fibers with gelatin and calcium phosphate and their use as biomimetic scaffolds for bone tissue engineering.Langmuir20082424141451415010.1021/la802984a 19053657
    [Google Scholar]
78. AhmedI. LiuH.Y. MamiyaP.C. Three-dimensional nanofibrillar surfaces covalently modified with tenascin-C-derived peptides enhance neuronal growth in vitro.J. Biomed. Mater. Res. A200676A485186010.1002/jbm.a.30587
    [Google Scholar]
79. YooH.S. KimT.G. ParkT.G. Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery.Adv. Drug Deliv. Rev.200961121033104210.1016/j.addr.2009.07.007 19643152
    [Google Scholar]
80. YangG.Z. LiJ.J. YuD.G. HeM.F. YangJ.H. WilliamsG.R. Nanosized sustained-release drug depots fabricated using modified tri-axial electrospinning.Acta Biomater.20175323324110.1016/j.actbio.2017.01.069 28137657
    [Google Scholar]
81. LiX. SuY. LiuS. TanL. MoX. RamakrishnaS. Encapsulation of proteins in poly(l-lactide-co-caprolactone) fibers by emulsion electrospinning.Colloids Surf. B Biointerfaces201075241842410.1016/j.colsurfb.2009.09.014 19836931
    [Google Scholar]
82. ZhangY.Z. WangX. FengY. LiJ. LimC.T. RamakrishnaS. Coaxial electrospinning of (fluorescein isothiocyanate-conjugated bovine serum albumin)-encapsulated poly(ε-caprolactone) nanofibers for sustained release.Biomacromolecules2006741049105710.1021/bm050743i 16602720
    [Google Scholar]
83. SuY. SuQ. LiuW. Controlled release of bone morphogenetic protein 2 and dexamethasone loaded in core–shell PLLACL–collagen fibers for use in bone tissue engineering.Acta Biomater.20128276377110.1016/j.actbio.2011.11.002 22100346
    [Google Scholar]
84. LiuW. NiC. ChaseD.B. RaboltJ.F. Preparation of multilayer biodegradable nanofibers by triaxial electrospinning.ACS Macro Lett.20132646646810.1021/mz4000688 35581798
    [Google Scholar]
85. FaldeE.J. FreedmanJ.D. HerreraV.L.M. YoheS.T. ColsonY.L. GrinstaffM.W. Layered superhydrophobic meshes for controlled drug release.J. Control. Release2015214232910.1016/j.jconrel.2015.06.042 26160309
    [Google Scholar]
86. OkudaT. TominagaK. KidoakiS. Time-programmed dual release formulation by multilayered drug-loaded nanofiber meshes.J. Control. Release2010143225826410.1016/j.jconrel.2009.12.029 20074599
    [Google Scholar]
87. ZhangZ. LiuS. QiY. Time-programmed DCA and oxaliplatin release by multilayered nanofiber mats in prevention of local cancer recurrence following surgery.J. Control. Release201623512513310.1016/j.jconrel.2016.05.046 27221069
    [Google Scholar]
88. HuX. LiuS. ZhouG. HuangY. XieZ. JingX. Electrospinning of polymeric nanofibers for drug delivery applications.J. Control. Release2014185122110.1016/j.jconrel.2014.04.018 24768792
    [Google Scholar]
89. YoheS.T. ColsonY.L. GrinstaffM.W. Superhydrophobic materials for tunable drug release: using displacement of air to control delivery rates.J. Am. Chem. Soc.201213442016201910.1021/ja211148a 22279966
    [Google Scholar]
90. JiW. YangF. van den BeuckenJ.J.J.P. Fibrous scaffolds loaded with protein prepared by blend or coaxial electrospinning.Acta Biomater.20106114199420710.1016/j.actbio.2010.05.025 20594971
    [Google Scholar]
91. HanD. YuX. ChaiQ. AyresN. StecklA.J. Stimuli-responsive self-immolative polymer nanofiber membranes formed by coaxial electrospinning.ACS Appl. Mater. Interfaces2017913118581186510.1021/acsami.6b16501 28263054
    [Google Scholar]
92. VerreckG. ChunI. RosenblattJ. Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer.J. Control. Release200392334936010.1016/S0168‑3659(03)00342‑0 14568415
    [Google Scholar]
93. XueJ. HeM. LiuH. Drug loaded homogeneous electrospun PCL/gelatin hybrid nanofiber structures for anti-infective tissue regeneration membranes.Biomaterials201435349395940510.1016/j.biomaterials.2014.07.060 25134855
    [Google Scholar]
94. CuiW. LiX. ZhuX. YuG. ZhouS. WengJ. Investigation of drug release and matrix degradation of electrospun poly(DL-lactide) fibers with paracetanol inoculation.Biomacromolecules2006751623162910.1021/bm060057z 16677047
    [Google Scholar]
95. YuD.G. LiX.Y. WangX. YangJ.H. BlighS.W.A. WilliamsG.R. Nanofibers fabricated using triaxial electrospinning as zero order drug delivery systems.ACS Appl. Mater. Interfaces2015733188911889710.1021/acsami.5b06007 26244640
    [Google Scholar]
96. ViryL. MoultonS.E. RomeoT. Emulsion-coaxial electrospinning: designing novel architectures for sustained release of highly soluble low molecular weight drugs.J. Mater. Chem.201222221134710.1039/c2jm31069d
    [Google Scholar]
97. DiasJ.R. GranjaP.L. BártoloP.J. Advances in electrospun skin substitutes.Prog. Mater. Sci.20168431433410.1016/j.pmatsci.2016.09.006
    [Google Scholar]
98. MaB. XieJ. JiangJ. WuJ. Sandwich-type fiber scaffolds with square arrayed microwells and nanostructured cues as microskin grafts for skin regeneration.Biomaterials201435263064110.1016/j.biomaterials.2013.09.111 24144904
    [Google Scholar]
99. XieJ. MacEwanM.R. RayW.Z. LiuW. SieweD.Y. XiaY. Radially aligned, electrospun nanofibers as dural substitutes for wound closure and tissue regeneration applications.ACS Nano2010495027503610.1021/nn101554u 20695478
    [Google Scholar]
100. NelsonM.T. ShortA. ColeS.L. Preferential, enhanced breast cancer cell migration on biomimetic electrospun nanofiber ‘cell highways’.BMC Cancer201414182510.1186/1471‑2407‑14‑825 25385001
     [Google Scholar]
101. Agudelo-GarciaP.A. De JesusJ.K. WilliamsS.P. Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signaling.Neoplasia2011139831IN2210.1593/neo.11612 21969816
     [Google Scholar]
102. Rnjak-KovacinaJ. WeissA.S. Increasing the pore size of electrospun scaffolds.Tissue Eng. Part B Rev.201117536537210.1089/ten.teb.2011.0235 21815802
     [Google Scholar]
103. JainV. JainS. MahajanS.C. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment.Curr. Drug Deliv.201512217719110.2174/1567201811666140822112516 25146439
     [Google Scholar]
104. ParkS.H. KimT.G. KimH.C. YangD.Y. ParkT.G. Development of dual scale scaffolds via direct polymer melt deposition and electrospinning for applications in tissue regeneration.Acta Biomater.2008451198120710.1016/j.actbio.2008.03.019 18458008
     [Google Scholar]
105. LuoY. SmithJ.V. Studies on molecular mechanisms of Ginkgo biloba extract.Appl. Microbiol. Biotechnol.200464446547210.1007/s00253‑003‑1527‑9 14740187
     [Google Scholar]
106. RujitanarojP. WangY.C. WangJ. ChewS.Y. Nanofiber-mediated controlled release of siRNA complexes for long term gene-silencing applications.Biomaterials201132255915592310.1016/j.biomaterials.2011.04.065 21596430
     [Google Scholar]
107. AboodyK.S. NajbauerJ. DanksM.K. Stem and progenitor cell-mediated tumor selective gene therapy.Gene Ther.2008151073975210.1038/gt.2008.41 18369324
     [Google Scholar]
108. PaulK.B. SinghV. VanjariS.R.K. SinghS.G. One step biofunctionalized electrospun multiwalled carbon nanotubes embedded zinc oxide nanowire interface for highly sensitive detection of carcinoma antigen-125.Biosens. Bioelectron.20178814415210.1016/j.bios.2016.07.114 27520500
     [Google Scholar]
109. HanS.W. KohW.G. Hydrogel-framed nanofiber matrix integrated with a microfluidic device for fluorescence detection of matrix metalloproteinases-9.Anal. Chem.201688126247625310.1021/acs.analchem.5b04867 27214657
     [Google Scholar]
110. BatesR. EdwardsN.S. YatesJ.D. Spheroids and cell survival.Crit. Rev. Oncol. Hematol.2000362-3617410.1016/S1040‑8428(00)00077‑9 11033297
     [Google Scholar]
111. ChenS. BodaS.K. BatraS.K. LiX. XieJ. Emerging roles of electrospun nanofibers in cancer research.Adv. Healthc. Mater.201876170102410.1002/adhm.201701024 29210522
     [Google Scholar]
112. AliM.A. MondalK. JiaoY. Microfluidic immuno-biochip for detection of breast cancer biomarkers using hierarchical composite of porous graphene and titanium dioxide nanofibers.ACS Appl. Mater. Interfaces2016832205702058210.1021/acsami.6b05648 27442623
     [Google Scholar]
113. AliM.A. MondalK. SinghC. Dhar MalhotraB. SharmaA. Anti-epidermal growth factor receptor conjugated mesoporous zinc oxide nanofibers for breast cancer diagnostics.Nanoscale20157167234724510.1039/C5NR00194C 25811908
     [Google Scholar]
114. SharmaA.K. TiwariA.K. DixitA.R. Effects of Minimum Quantity Lubrication (MQL) in machining processes using conventional and nanofluid based cutting fluids: A comprehensive review.J. Clean. Prod.201612711810.1016/j.jclepro.2016.03.146
     [Google Scholar]
115. XueR. BeheraP. XuJ. ViapianoM.S. LannuttiJ.J. Polydimethylsiloxane core–polycaprolactone shell nanofibers as biocompatible, real-time oxygen sensors.Sens. Actuators B Chem.201419269770710.1016/j.snb.2013.10.084 25006274
     [Google Scholar]
116. HuangP. LiZ. LinJ. Photosensitizer-conjugated magnetic nanoparticles for in vivo simultaneous magnetofluorescent imaging and targeting therapy.Biomaterials201132133447345810.1016/j.biomaterials.2011.01.032 21303717
     [Google Scholar]
117. HouZ. LiC. MaP. Up-conversion luminescent and porous NaYF4:Yb3+, Er3+@SiO2 nanocomposite fibers for anti-cancer drug delivery and cell imaging.Adv. Funct. Mater.201222132713272210.1002/adfm.201200082
     [Google Scholar]
118. PlaksV KoopmanCD WerbZ Circulating tumor cells.Science (80-)201334161511186118810.1126/science.1235226
     [Google Scholar]
119. GeigerT.R. PeeperD.S. Metastasis mechanisms.Biochim. Biophys. Acta200917962293308 19683560
     [Google Scholar]
120. HouS. ZhaoL. ShenQ. Polymer nanofiber-embedded microchips for detection, isolation, and molecular analysis of single circulating melanoma cells.Angew. Chem. Int. Ed.201352123379338310.1002/anie.201208452 23436302
     [Google Scholar]
121. XuX. Farach-CarsonM.C. JiaX. Three-dimensional in vitro tumor models for cancer research and drug evaluation.Biotechnol. Adv.20143271256126810.1016/j.biotechadv.2014.07.009 25116894
     [Google Scholar]
122. FidlerI.J. The organ microenvironment and cancer metastasis.Differentiation2002709-1049850510.1046/j.1432‑0436.2002.700904.x 12492492
     [Google Scholar]
123. JaaloukD.E. LammerdingJ. Mechanotransduction gone awry.Nat. Rev. Mol. Cell Biol.2009101637310.1038/nrm2597 19197333
     [Google Scholar]
124. SiY. YuJ. TangX. GeJ. DingB. Ultralight nanofibre-assembled cellular aerogels with superelasticity and multifunctionality.Nat. Commun.201451580210.1038/ncomms6802 25512095
     [Google Scholar]
125. WeigeltB. PeterseJ.L. van’t VeerL.J. Breast cancer metastasis: markers and models.Nat. Rev. Cancer20055859160210.1038/nrc1670 16056258
     [Google Scholar]
126. ZhangJ.H. TangJ. WangJ. Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model.Int. J. Oncol.20032341043104810.3892/ijo.23.4.1043 12963984
     [Google Scholar]
127. ChenZ. ChenZ. ZhangA. HuJ. WangX. YangZ. Electrospun nanofibers for cancer diagnosis and therapy.Biomater. Sci.20164692293210.1039/C6BM00070C 27048889
     [Google Scholar]
128. ChewS. WenY. DzenisY. LeongK. The role of electrospinning in the emerging field of nanomedicine.Curr. Pharm. Des.200612364751477010.2174/138161206779026326 17168776
     [Google Scholar]
129. LiuX. XuH. ZhangM. YuD.G. Electrospun medicated nanofibers for wound healing: Review.Membranes (Basel)2021111077010.3390/membranes11100770 34677536
     [Google Scholar]
130. BabalooH. VojoudiE. Application of electrospun nanofiber as drug delivery systems: A review.Pharm. Nanotechnol.2023111102410.2174/2211738510666220928161957 36173055
     [Google Scholar]